Hoffman William's Form 4 filing
Inari Medical, Inc. (NARI) · filed Sep 12, 2022
- Accession no.
- 0001127602-22-022348
- Filed
- Sep 12, 2022
- Trade date
- Sep 9, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.05M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman WilliamCIK 0001304099 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2022 | Common Stock | SSaleDisposed | −1,984 | $75.69 | −$150,168.96 | 360,609 | Direct | |
| Sep 9, 2022 | Common Stock | SSaleDisposed | −5,533 | $76.79 | −$424,879.07 | 355,076 | Direct | |
| Sep 9, 2022 | Common Stock | SSaleDisposed | −6,175 | $77.64 | −$479,427 | 348,901 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.